Hungry For Stability? 5 High-Yield Dividend Stocks To Consider

 | Mar 09, 2016 05:45AM ET

Recent market turmoil has reignited investor appetite for the safe and staid. Of course, when it comes to the markets, there’s never a 100% guarantee of safety, but because they can be relatively stable and reliable, higher yield (3%+) dividend paying stocks are back in vogue . According to the Wall St. Journal:

This year, stocks in the S&P High Yield Dividend Aristocrats Index—companies in the S&P Composite 1500 that have increased their dividends every year for at least 20 years—are up 1.91%, including dividends, compared with a negative total return of 4.3% for the S&P 500 Index. The total return on the Dow Jones U.S. Dividend 100 Index, composed of stocks that offer consistent, high payouts, is negative 0.8%.

Simply investing in dividend paying companies isn’t a guarantee that you’ll profit from the investment. And a high yield stock isn’t necessarily a safe haven. Reliable is the key here, since some companies intentionally beef up their dividend yields to unsustainable levels in order to attract investors, thereby up their share price.

On the other hand, some companies are thriving, and even if their stock remains relatively flat during specific market cycles, they’ve paid out—and consistently raised—dividends for years. That sort of past performance is a good indicator of future results.

Here’s our list of the top 5 dividend stocks with high yields that have been raising dividends almost every year for at least the past 30 years.

5. AbbVie (NYSE:ABBV)

AbbVie is a pharmaceuticals company focused on the research and development of biopharmaceuticals and small molecule drugs. It employs about 28,000 people and has a market cap of $90B.

Although, AbbVie has only been paying dividends for the past 3 years, it has a good excuse: it’s a spin-off of Abbott Laboratories (NYSE:ABT), a Dividend Aristocrat that's raised its dividend payout for 20 consecutive years. And since the acorn doesn’t fall far from the tree (in this case at least) it seems fair to include AbbVie on our list, since it has continued Abbott's tradition of raising its dividend annually.

AbbVie shareholders enjoy a significant dividend yield of 4.12% along with a 43 year tradition of dividends from its ‘parent’ company. At $56.40 per share as of yesterday’s close, AbbVie also trades for a reasonable P/E ratio of 13.1, compared to the industry average of 38.07.